期刊文献+

静脉注射多西他赛亚微乳在大鼠的组织分布及排泄研究 被引量:2

Tissue distribution and excretion of docetaxel submicron emulsion
在线阅读 下载PDF
导出
摘要 目的研究比较多西他赛(docetaxel,DTX)亚微乳注射剂及普通注射剂在大鼠体内的组织分布及原型药物的排泄情况。方法以DTX注射剂(商品名:泰索帝)为参比,48只SD大鼠随机分成2组,分别经尾静脉注射DTX亚微乳注射剂(75 mg.m-2)和DTX注射剂(75 mg.m-2),在给药后5、30、60、300 min各处死6只大鼠,于相应部位取各组织适量。另取大鼠10只,随机分为2组,分别静脉注射亚微乳注射剂或普通注射剂(75 mg.m-2),收集给药前及给药后0~4、4~10、10~18、18~24、24~36 h的尿液、粪便。组织及排泄物中的DTX浓度以HPLC-UV法测定。结果 DTX亚微乳注射剂及普通注射剂在体内分布广泛而迅速。DTX亚微乳在心和肺中的浓度显著低于注射剂(P〈0.05),但在脾脏中的浓度高于注射剂(P〈0.05)。肾脏中的分布在早期较注射剂明显增加,后期较注射剂明显降低(P〈0.05),其他组织器官的分布无显著性差异(P〉0.05)。两者经粪便和尿液排泄的原型药物无显著性差异(P〉0.05),36 h尿排累积百分率均〈2%,粪排累积百分率均〈6%。结论与普通注射剂相比,亚微乳不影响DTX在大鼠体内的原型药物排泄。在安全性及药效学评价中,应特别关注剂型改变后心、肺、肾及脾脏的毒性及药效变化。 Objective To investigate tissue distribution and excretion of docetaxel submicron emulsion in rats.Methods A high performance liquid chromatography(HPLC) with UV detection was developed to study the concentration of docetaxel in the biological samples.Taking paclitaxel as an internal standard,48 SD rats were randomly divided into 2 groups:test preparation and reference preparation,and each group was intravenously administered 75 mg·m-2 DTX.The rats were executed at 5,30,60 and 300 min,and tissues were taken in the same location to determine the content.Results The docetaxel submicron emulsion was widely distributed in the tissues of the body.The docetaxel concentration of the test group in the heart and lung was lower than that of the reference group(P〈0.05),but higher than the reference group in the spleen(P〈0.05).In the kidney,the docetaxel concentration of the test group increased quickly before 30 min and was higher than the reference group(P〈0.05),and after that the concentration decreased even lower than the reference injection(P〈0.05).The docetaxel concentrations of the 2 groups in other tissues and organs had no significant difference(P〉0.05).The excretion of the parent drug in the urine and excrement amounted to 2% and 6% of the dose,respectively.Conclusion Submicron emulsion has no significant effect on docetaxel distribution and the preparation is delivered effectively.In safety and pharmacodynamic evaluation,we should pay more attention to the alteration of toxicity and therapeutic effect after changing dosage forms.
出处 《中南药学》 CAS 2011年第6期409-413,共5页 Central South Pharmacy
基金 国家科技型中小企业创新基金资助项目(No.:07C26214601864)
关键词 多西他赛 亚微乳 组织分布 排泄 docetaxel submicron emulsion distributionl excretion
  • 相关文献

参考文献5

二级参考文献70

共引文献46

同被引文献30

  • 1张晓君,王东凯,姚建美,韩晓,王玉.可注射丹参酮ⅡA自微乳制剂的处方筛选及化学稳定性考察[J].中国药剂学杂志(网络版),2010(5):117-125. 被引量:4
  • 2龚明涛,张钧寿,沈益.羟基喜树碱纳米乳的制备及其抗癌作用初步研究[J].中国天然药物,2005,3(1):41-43. 被引量:25
  • 3毛世瑞,张磊,李茗,毕波,毕殿洲.硫酸沙丁胺醇油包水型口服纳米乳的制备及小肠吸收考察[J].沈阳药科大学学报,2005,22(6):401-404. 被引量:10
  • 4于力,张钧寿,周建平.纳米乳的研究及其在制剂学领域的应用[J].药学进展,2006,30(11):491-497. 被引量:38
  • 5Gannu R, Palem C R, Yamsani V V, et al. Enhanced bioavailabili- ty of lacidipine via microemulsion based transdermal gels: formu- lation optimization, ex vivo and in vivo characterization[J]. Interna- tional Journal of Pharmaceutics, 2010, 388 (1-2): 231-241.
  • 6Neubert R H H. Potentials of new nanocarriers for dermal and transdermal drugdelivery[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2011, 77 ( 1 ): 1-2.
  • 7泰金淼.多潘立酮微米乳的制备及药效学研究[D].杨凌:西北农林科技大学,2009.
  • 8Pouton C W. Formulation of self-emulsifying drug delivery system [J]. Adv Drug Deliv Rev, 1997, 25(1): 47-58.
  • 9Lvovich V F, Matthews E, Riga A T, et al. AC electrokinetic plat- form for iontophoretic transdermal drug delivery[J]. Journal of Controlled Release, 2010, 145(2): 1.34-140.
  • 10Tsai Y H, Lee K F, Huang Y B, et al. In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system[J]. International Journal of Pharmaceutics, 2010, 388 ( 1 ): 257-262.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部